Global Peptide Screening Service Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256117

Publication Date:

February 28, 2025

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Peptide Screening Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Peptide Screening Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Peptide Screening Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Peptide Screening Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Peptide Screening Service players cover Pepscan, Orbit Discovery, Creative Biolabs, GenScript, Creative Peptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧eptide Screening Service Industry Forecast鈥� looks at past sales and reviews total world Peptide Screening Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Screening Service sales for 2025 through 2031. With Peptide Screening Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Screening Service industry.
This Insight Report provides a comprehensive analysis of the global Peptide Screening Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Screening Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peptide Screening Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Screening Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Screening Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Screening Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Solid-Phase Screening
Solution-Sorting Screening
Cell-based Screening
In Vivo Screening
Ex Vivo Screening
Segmentation by Application:
Structural Biology
Peptide Drug Development
Vaccine Development
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pepscan
Orbit Discovery
Creative Biolabs
GenScript
Creative Peptides
Eurogentec
Bio-Synthesis
JPT Peptide Technologies
Antibody Design Labs
HLA Proteins
Synbio Technologies
Lugen SCI
Quimigen
IRBM
BIOSTEM

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptide Screening Service Market Size (2020-2031)
2.1.2 Peptide Screening Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Peptide Screening Service by Country/Region (2020, 2024 & 2031)
2.2 Peptide Screening Service Segment by Type
2.2.1 Solid-Phase Screening
2.2.2 Solution-Sorting Screening
2.2.3 Cell-based Screening
2.2.4 In Vivo Screening
2.2.5 Ex Vivo Screening
2.3 Peptide Screening Service Market Size by Type
2.3.1 Peptide Screening Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Peptide Screening Service Market Size Market Share by Type (2020-2025)
2.4 Peptide Screening Service Segment by Application
2.4.1 Structural Biology
2.4.2 Peptide Drug Development
2.4.3 Vaccine Development
2.5 Peptide Screening Service Market Size by Application
2.5.1 Peptide Screening Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Peptide Screening Service Market Size Market Share by Application (2020-2025)
3 Peptide Screening Service Market Size by Player
3.1 Peptide Screening Service Market Size Market Share by Player
3.1.1 Global Peptide Screening Service Revenue by Player (2020-2025)
3.1.2 Global Peptide Screening Service Revenue Market Share by Player (2020-2025)
3.2 Global Peptide Screening Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide Screening Service by Region
4.1 Peptide Screening Service Market Size by Region (2020-2025)
4.2 Global Peptide Screening Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide Screening Service Market Size Growth (2020-2025)
4.4 APAC Peptide Screening Service Market Size Growth (2020-2025)
4.5 Europe Peptide Screening Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Peptide Screening Service Market Size Growth (2020-2025)
5 Americas
5.1 Americas Peptide Screening Service Market Size by Country (2020-2025)
5.2 Americas Peptide Screening Service Market Size by Type (2020-2025)
5.3 Americas Peptide Screening Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Screening Service Market Size by Region (2020-2025)
6.2 APAC Peptide Screening Service Market Size by Type (2020-2025)
6.3 APAC Peptide Screening Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide Screening Service Market Size by Country (2020-2025)
7.2 Europe Peptide Screening Service Market Size by Type (2020-2025)
7.3 Europe Peptide Screening Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide Screening Service by Region (2020-2025)
8.2 Middle East & Africa Peptide Screening Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Peptide Screening Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Peptide Screening Service Market Forecast
10.1 Global Peptide Screening Service Forecast by Region (2026-2031)
10.1.1 Global Peptide Screening Service Forecast by Region (2026-2031)
10.1.2 Americas Peptide Screening Service Forecast
10.1.3 APAC Peptide Screening Service Forecast
10.1.4 Europe Peptide Screening Service Forecast
10.1.5 Middle East & Africa Peptide Screening Service Forecast
10.2 Americas Peptide Screening Service Forecast by Country (2026-2031)
10.2.1 United States Market Peptide Screening Service Forecast
10.2.2 Canada Market Peptide Screening Service Forecast
10.2.3 Mexico Market Peptide Screening Service Forecast
10.2.4 Brazil Market Peptide Screening Service Forecast
10.3 APAC Peptide Screening Service Forecast by Region (2026-2031)
10.3.1 China Peptide Screening Service Market Forecast
10.3.2 Japan Market Peptide Screening Service Forecast
10.3.3 Korea Market Peptide Screening Service Forecast
10.3.4 Southeast Asia Market Peptide Screening Service Forecast
10.3.5 India Market Peptide Screening Service Forecast
10.3.6 Australia Market Peptide Screening Service Forecast
10.4 Europe Peptide Screening Service Forecast by Country (2026-2031)
10.4.1 Germany Market Peptide Screening Service Forecast
10.4.2 France Market Peptide Screening Service Forecast
10.4.3 UK Market Peptide Screening Service Forecast
10.4.4 Italy Market Peptide Screening Service Forecast
10.4.5 Russia Market Peptide Screening Service Forecast
10.5 Middle East & Africa Peptide Screening Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Peptide Screening Service Forecast
10.5.2 South Africa Market Peptide Screening Service Forecast
10.5.3 Israel Market Peptide Screening Service Forecast
10.5.4 Turkey Market Peptide Screening Service Forecast
10.6 Global Peptide Screening Service Forecast by Type (2026-2031)
10.7 Global Peptide Screening Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Peptide Screening Service Forecast
11 Key Players Analysis
11.1 Pepscan
11.1.1 Pepscan Company Information
11.1.2 Pepscan Peptide Screening Service Product Offered
11.1.3 Pepscan Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pepscan Main Business Overview
11.1.5 Pepscan Latest Developments
11.2 Orbit Discovery
11.2.1 Orbit Discovery Company Information
11.2.2 Orbit Discovery Peptide Screening Service Product Offered
11.2.3 Orbit Discovery Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Orbit Discovery Main Business Overview
11.2.5 Orbit Discovery Latest Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Information
11.3.2 Creative Biolabs Peptide Screening Service Product Offered
11.3.3 Creative Biolabs Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Creative Biolabs Main Business Overview
11.3.5 Creative Biolabs Latest Developments
11.4 GenScript
11.4.1 GenScript Company Information
11.4.2 GenScript Peptide Screening Service Product Offered
11.4.3 GenScript Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 GenScript Main Business Overview
11.4.5 GenScript Latest Developments
11.5 Creative Peptides
11.5.1 Creative Peptides Company Information
11.5.2 Creative Peptides Peptide Screening Service Product Offered
11.5.3 Creative Peptides Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Creative Peptides Main Business Overview
11.5.5 Creative Peptides Latest Developments
11.6 Eurogentec
11.6.1 Eurogentec Company Information
11.6.2 Eurogentec Peptide Screening Service Product Offered
11.6.3 Eurogentec Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Eurogentec Main Business Overview
11.6.5 Eurogentec Latest Developments
11.7 Bio-Synthesis
11.7.1 Bio-Synthesis Company Information
11.7.2 Bio-Synthesis Peptide Screening Service Product Offered
11.7.3 Bio-Synthesis Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bio-Synthesis Main Business Overview
11.7.5 Bio-Synthesis Latest Developments
11.8 JPT Peptide Technologies
11.8.1 JPT Peptide Technologies Company Information
11.8.2 JPT Peptide Technologies Peptide Screening Service Product Offered
11.8.3 JPT Peptide Technologies Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 JPT Peptide Technologies Main Business Overview
11.8.5 JPT Peptide Technologies Latest Developments
11.9 Antibody Design Labs
11.9.1 Antibody Design Labs Company Information
11.9.2 Antibody Design Labs Peptide Screening Service Product Offered
11.9.3 Antibody Design Labs Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Antibody Design Labs Main Business Overview
11.9.5 Antibody Design Labs Latest Developments
11.10 HLA Proteins
11.10.1 HLA Proteins Company Information
11.10.2 HLA Proteins Peptide Screening Service Product Offered
11.10.3 HLA Proteins Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 HLA Proteins Main Business Overview
11.10.5 HLA Proteins Latest Developments
11.11 Synbio Technologies
11.11.1 Synbio Technologies Company Information
11.11.2 Synbio Technologies Peptide Screening Service Product Offered
11.11.3 Synbio Technologies Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Synbio Technologies Main Business Overview
11.11.5 Synbio Technologies Latest Developments
11.12 Lugen SCI
11.12.1 Lugen SCI Company Information
11.12.2 Lugen SCI Peptide Screening Service Product Offered
11.12.3 Lugen SCI Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lugen SCI Main Business Overview
11.12.5 Lugen SCI Latest Developments
11.13 Quimigen
11.13.1 Quimigen Company Information
11.13.2 Quimigen Peptide Screening Service Product Offered
11.13.3 Quimigen Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Quimigen Main Business Overview
11.13.5 Quimigen Latest Developments
11.14 IRBM
11.14.1 IRBM Company Information
11.14.2 IRBM Peptide Screening Service Product Offered
11.14.3 IRBM Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 IRBM Main Business Overview
11.14.5 IRBM Latest Developments
11.15 BIOSTEM
11.15.1 BIOSTEM Company Information
11.15.2 BIOSTEM Peptide Screening Service Product Offered
11.15.3 BIOSTEM Peptide Screening Service Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 BIOSTEM Main Business Overview
11.15.5 BIOSTEM Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂